Hamps Bio Limited Financials

Hamps Bio Limited Financial Statement

Hamps Bio Limited Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Hamps Bio Limited Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	6.48	5.58	5.34
Operating Expenses Annual	5.30	4.71	4.73
Operating Profit Annual	1.20	0.87	0.62
Interest Annual	0.15	0.18	0.19
Depreciation	0.40	0.34	0.33
Net Profit Annual	0.50	0.36	0.12
Tax Annual	0.15	-0.00	-0.02

Particulars	Mar 2024
Total Revenue Annual	6.48
Operating Expenses Annual	5.30
Operating Profit Annual	1.20
Interest Annual	0.15
Depreciation	0.40
Net Profit Annual	0.50
Tax Annual	0.15

Hamps Bio Limited Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.05	0.05	0.15
Cash Flow from Operations	-0.29	1.23	0.33
Cash Flow from Investing	-0.37	-0.75	0.51
Cash Flow from Financing	0.67	-0.48	-0.94
Cash Flow at the End	0.06	0.05	0.05

Particulars	Mar 2024
Cash Flow at the Beginning	0.05
Cash Flow from Operations	-0.29
Cash Flow from Investing	-0.37
Cash Flow from Financing	0.67
Cash Flow at the End	0.06

Hamps Bio Limited Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	18.52	15.77	11.61
PBIT Margin (%)	12.35	9.68	5.43
PBT Margin (%)	-69.90	-44.08	-23.22
Net PROFIT Margin (%)	7.72	6.45	2.25
Return On Networth / Equity (%)	20.53	24	8
Return On Networth /Employed (%)	20.59	15.72	8.08
Return On Assets (%)	13.12	11.55	3.89
Total Debt / Equity (X)	0.59	1.59	2.02
Asset Turnover Ratio (%)	1.70	1.79	1.73

Particulars	Mar 2024
PBDIT Margin (%)	18.52
PBIT Margin (%)	12.35
PBT Margin (%)	-69.90
Net PROFIT Margin (%)	7.72
Return On Networth / Equity (%)	20.53
Return On Networth /Employed (%)	20.59
Return On Assets (%)	13.12
Total Debt / Equity (X)	0.59
Asset Turnover Ratio (%)	1.70

Hamps Bio Limited Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	2.56	2.61	2.15
Total Current Assets Annual	2.44	1.23	1.33
Non Current Assets Annual	2.71	2.73	2.31
Total Shareholders Funds Annual	3.37	1.36	1.01
Total Assets Annual	5.15	3.96	3.64

Particulars	Mar 2024
Fixed Assets Annual	2.56
Total Current Assets Annual	2.44
Non Current Assets Annual	2.71
Total Shareholders Funds Annual	3.37
Total Assets Annual	5.15

Hamps Bio Limited Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Jan 18, 2025, Hamps Bio Limited has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Hamps Bio Limited is debt-free with a debt-to-equity ratio of 0.31.

In FY 2024 , Hamps Bio Limited recorded a total revenue of approximately 6.48 Cr marking a significant milestone in the company's financial performance.

Hamps Bio Limited's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.1% annually, respectively..

Hamps Bio Limited's current PE ratio is undefined.

Hamps Bio Limited's ROCE averaged 14.8% from the FY ending March 2022 to 2024, with a median of 17.0%. It peaked at 17.8% in March 2024, reflecting strong capital efficiency over the period..

Hamps Bio Limited's latest EBIT is Rs. 0.80 Cr, surpassing the average EBIT of Rs. 0.54 Cr over the 5 years..